Home › Mild Cognitive Impairment › California › Orange
Mild Cognitive Impairment clinical trials in Orange, CA
4 studies for Mild Cognitive Impairment are looking for participants at sites in and around Orange (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
RecruitingPhase 4
- ATP Clinical Research, Inc - Orange, Orange
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
Recruiting
- Saddleback Medical Center, Orange
Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
RecruitingPhase 1/2
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Study of ALTO-101 in Patients With Schizophrenia
RecruitingPhase 2
- Site 5106, Orange
About Mild Cognitive Impairment
In mild cognitive impairment (MCI), you have more memory and thinking problems than others your age, but they don't interfere with your everyday life.
More about Mild Cognitive Impairment on MedlinePlus
Mild Cognitive Impairment trials in other cities
- New York City, NY24 studies
- Boston, MA23 studies
- Chicago, IL16 studies
- Baltimore, MD14 studies
- Los Angeles, CA12 studies
- Miami, FL12 studies
- San Francisco, CA11 studies
- Atlanta, GA10 studies
- Houston, TX10 studies
- Birmingham, AL10 studies
- Philadelphia, PA10 studies
- Durham, NC9 studies
Other studies in Orange
- Non-Small Cell Lung Cancer28 studies
- Metastatic Cancer21 studies
- Ovarian Cancer16 studies
- Colorectal Cancer16 studies
- Cancer (all types)15 studies
- Pancreatic Cancer15 studies
- Lung Cancer15 studies
- Liver Cancer (Hepatocellular Carcinoma)14 studies
- Melanoma14 studies
- Major Depressive Disorder13 studies
- Stomach Cancer13 studies
- Prostate Cancer13 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.